Vanesa GREGORC

Candiolo Cancer Institute

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Research Cancer Research professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (9)

Alessandro Cerutti

Candiolo Cancer Institute, FPO-IRCCS

ITALY

View details

Gunnar Folprecht

University Hospital Carl Gustav Carus

GERMANY

View details

Giorgio V Scagliotti

University of Turin

ITALY

View details

Mauro Papotti

University of Turin

ITALY

View details

Francesca Romana Giglioli

Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino

ITALY

View details

Francesco Giuseppe DE ROSA

Associate Professor, Infectious Diseases

University of Turin

ITALY

View details

Riccarda GRANATA

Associate Professor in Endocrinology

University of Turin

ITALY

View details

Cristina Federici

Istituto Superiore di Sanità

ITALY

View details

Andrew Schally

University of Miami Miller School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vanesa GREGORC

Research Interests

Explore related searches

Contact this professor

Articles (10)

Growth Hormone-Releasing Hormone Antagonists Increase Radiosensitivity in Non-Small Cell Lung Cancer Cells

Survival Outcomes of Luminal Metastatic Breast Cancer Patients According to Changes in Molecular Subtype at Re-Biopsy: Insights from the GIM-13—AMBRA Study

Overlapping Infection by <i>Strongyloides</i> spp. and Cytomegalovirus in the Immunocompromised Host: A Comprehensive Review of the Literature

International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer

Angiogenesis inhibition in lung cancer: Emerging novel strategies

Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors

Venoarterial Extracorporeal Membrane Oxygenation Support in Lung Cancer Resection

Eruptive cherry angiomas and uveal melanoma: beyond a simple association

Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study

Collaborators (9)

Alessandro Cerutti

Gunnar Folprecht

Giorgio V Scagliotti

Mauro Papotti

Francesca Romana Giglioli

Francesco Giuseppe DE ROSA

Riccarda GRANATA

Cristina Federici

Andrew Schally

Make your next move.